NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT04731467 2024-12-27A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsPurple Biotech Ltd.Phase 1/2 Completed79 enrolled